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Objectives This study was performed to evaluate the physiological and clinical outcomes of frac-
tional ﬂow reserve (FFR)-guided revascularization strategy with drug-eluting stents in serial stenoses
within the same coronary artery.
Background Identifying a functionally signiﬁcant stenosis is difﬁcult when several stenoses exist
within 1 coronary artery.
Methods A total of 131 patients (141 vessels and 298 lesions) with multiple intermediate stenoses
within the same coronary artery were assessed by FFR with pullback pressure tracings. In vessels
with an FFR 0.8, the stenosis that caused the largest pressure step-up was stented ﬁrst. Major ad-
verse cardiac events were assessed during follow-up.
Results FFR was measured 239 times and there were no procedure-related complications. There
was a weak negative correlation between FFR and angiographic percent diameter stenosis
(r  0.282, p  0.001). In total, 116 stents were implanted and revascularization was deferred in
61.1% (182 of 298) of lesions. When the vessels with an initial FFR 0.8 were divided into 2 groups
according to FFR after ﬁrst stenting (FFR 0.8 vs. FFR 0.8), there were no differences in baseline
angiographic and physiological parameters between the 2 groups. During the mean follow-up of
501  311 days, there was only 1 target vessel revascularization due to in-stent restenosis. There
were no events related to deferred lesions.
Conclusions FFR-guided revascularization strategy using pullback pressure tracing in serial stenoses was
safe and effective. This strategy can reduce unnecessary intervention and maximize the beneﬁt of percu-
taneous coronary intervention with drug-eluting stents in patients with multiple stenoses within 1 coronary
artery. (J Am Coll Cardiol Intv 2012;5:1013–8) © 2012 by the American College of Cardiology Foundation
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1014The presence of myocardial ischemia is a major prognostic
factor in patients with symptomatic coronary artery disease
(1,2) and the decision to perform revascularization should be
guided based on the presence of myocardial ischemia. Frac-
tional flow reserve (FFR) is a reliable physiological parameter
to determine the functional significance of coronary stenosis
(3,4). FFR-guided revascularization strategy was reported to be
safe and effective in patients with various lesion subsets (5–8).
However, identification of the culprit lesion, which causes
myocardial ischemia and warrants revascularization, is chal-
lenging in patients with diffuse disease or multiple sequential
stenoses with intermediate severity.
See page 1019
In patients with multiple stenoses of intermediate severity
in 1 coronary artery, FFR measurements with pullback
pressure recording can be helpful to identify the lesion that
has functional significance (9,10). Although more and more
patients with complex coronary lesions are now treated with
drug-eluting stents (DES), the outcomes of this strategy in
the era of DES have not yet been fully evaluated.
We performed this study to eval-
uate the physiological and clinical
outcomes of FFR-guided revascu-
larization strategy with DES in pa-
tients with serial stenoses within 1
coronary artery.
Methods
Study subjects. Between March
009 and December 2011, patients who underwent elective
oronary angiography and had multiple intermediate steno-
es in the same epicardial coronary artery (vessel size 2
m in diameter) were prospectively enrolled from 2 Korean
enters. An intermediate stenosis was defined as 40% to
0% diameter stenosis by visual assessment. To be included,
ach lesion should be separated by an angiographically
ormal-looking segment of at least 20 mm. Patients were
xcluded if any of the following were present: in-stent
estenosis, acute ST-segment elevation myocardial infarc-
ion, regional wall motion abnormalities of a target vessel
egment, left ventricular ejection fraction 40%, primary
yocardial or valvular disease, contraindication to adeno-
ine, or angiographically visible thrombus at a target lesion.
n patients with acute coronary syndrome, only the noncul-
rit vessels were included. The study protocol was approved
y the Institutional Review Board of each participating
ospital and informed consent was obtained from every
tudy participant.
Procedures. Target vessel engagement was performed via
Abbreviations
and Acronyms
DES  drug-eluting stent(s)
FFR  fractional flow
reserve
PCI  percutaneous
coronary interventionadial or femoral approach using 5-F to 7-F guide catheters. Sngiographic images were acquired after intracoronary
itroglycerin (100 to 200 g) administration. FFR was
easured using a 0.014-inch pressure guidewire (St. Jude
edical, Minneapolis, Minnesota) as previously described
4) and hyperemia was induced by the continuous intrave-
ous infusion of adenosine (140 g/kg/min). The pressure
ire was initially positioned distal to the most distal lesion,
nd FFR was measured. FFR was calculated as the mean
istal coronary pressure divided by the mean aortic pressure
uring maximal hyperemia and functional significance was
efined with the threshold of FFR 0.8 (11). In vessels
ith an FFR0.8, the pressure wire was slowly pulled back
o the ostium of the coronary artery under steady-state
yperemia and the stenosis that caused the largest pressure
tep-up (primary target lesion) during pressure wire pull-
ack was treated first. Percutaneous coronary intervention
PCI) of other stenoses was determined by FFR measured
fter stenting of the primary target lesion. In this study,
pparent and true FFR of nonprimary target lesion were
alculated. Apparent FFR was defined as the initial ratio of
roximal and distal pressures across the nonprimary target
esion, and true FFR was defined as the ratio of pressures
cross that stenosis after the stenosis of a primary target
esion was eliminated by PCI (9,10) (Fig. 1). All pressure
racings were recorded on the RadiAnalyzer Xpress (St. Jude
edical) for offline analysis. All PCI procedures were
erformed using DES.
Quantitative coronary angiography. Quantitative coronary an-
iography was performed by an independent core laboratory at
eoul National University Cardiovascular Center. Quantitative
oronary angiography was performed by a single experienced
bserver who was unaware of FFR findings. Using the guide
atheter for calibration and an edge detection system (CAAS,
ersion 5.7, QCA System, Pie Medical, Maastricht, the Nether-
ands), the reference diameter, minimum lumen diameter, and
esion length were measured, and the percentage of diameter
tenosis was calculated.
Follow-up. Patients were recommended to visit the hospital
for follow-up at 1, 6, and 12 months after initial angiogra-
phy. Information relating to major adverse cardiac events,
including cardiac death, target vessel-related myocardial
infarction, and revascularization, was collected. Telephone
contact was performed if necessary. There was no loss to
follow-up in this study.
Statistical analysis. Data were expressed as mean  SD for
continuous variables and percentages for categorical vari-
ables. Comparison of continuous variables was performed
using the Student t test or paired t test. Analysis of discrete
ariables was performed using the chi-square test. Pearson
orrelation was used to calculate the association between
ngiographic stenosis and FFR as well as between apparent
nd true FFR. The value of p  0.05 was considered as
ignificant. All statistical analyses were performed using
PSS (version 16.0, SPSS Inc., Chicago, Illinois).
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1015Results
Among 161 eligible coronary arteries with 2 or more
intermediate stenoses, 20 were excluded (10 protocol viola-
tions, 6 pressure tracing artifacts, 3 bypass surgeries, and 1
Figure 1. Representative Case of FFR with Pullback Pressure Tracing-Guid
(A, B) Two consecutive intermediate stenoses (labeled a and b with arrows) w
(FFR) was 0.48, pullback pressure tracing was performed while simultaneously
FFR (yellow line). Two step-ups of intracoronary pressure were observed durin
a and b were 0.67 (ratio of pressures across lesion a  60/90) and 0.75 (ratio o
was observed across lesion a (30 mm Hg) than lesion b (16 mm Hg), the prox
formed. (C, D) After stenting lesion a (C), pullback pressure tracings (D) were
was 20 mm Hg. Therefore, stenting to the distal stenosis followed. True FFR o
lesions, FFR was 0.85 and no signiﬁcant pressure step-up was found across lesballoon angioplasty), and 141 coronary arteries (131 patientsand 298 lesions) were finally analyzed in this study. Sixteen
vessels had 3 stenoses and the other 125 vessels had 2
stenoses. Baseline clinical characteristics of study patients
and angiographic findings were summarized in Table 1. The
most commonly involved artery was the left anterior de-
I
bserved in the left anterior descending artery. As the fractional ﬂow reserve
oring the intracoronary pressure (green line), aortic pressure (red line), and
lback pressure tracing under maximal hyperemia (B). Apparent FFR of lesions
sures across lesion b  45/60), respectively. As the larger pressure step-up
enosis was regarded as the primary target lesion and stenting was per-
med again. FFR was 0.59 and intracoronary pressure step-up across lesion b
b was 0.73 (55/75 mm Hg). (E, F) After stenting both proximal and distal
or lesion b. PCI  percutaneous coronary intervention.ed PC
ere o
monit
g pul
f pres
imal st
perfor
f lesionscending coronary artery (95 vessels, 67.4%). The mean
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1016diameter stenosis was 51.6  13.2% and 167 (56%) of 298
esions had 50% stenosis.
FFR was measured 239 times in total, and there were no
rocedure-related complications. The association between
FR and angiographic stenosis of the most severe lesion in
target vessel is shown in Figure 2. There was a weak
egative correlation between FFR and angiographic percent
Table 1. Clinical and Angiographic Characteristics
Age, yrs 63.8 9.2
Male 88 (66.2)
Previous history
Diabetes 47 (35.9)
Hypertension 82 (62.6)
Hypercholesterolemia 52 (39.7)
Current smoking 24 (18.3)
Stable angina 64 (48.9)
Unstable angina 29 (22.1)
Multivessel disease 88 (66.1)
Left ventricular ejection fraction 61.4 7.6
Angiographic characteristics
Involved arteries, 141 vessels
Left anterior descending artery 95 (67.4)
Left circumﬂex artery 21 (14.9)
Right coronary artery 25 (17.7)
Quantitative coronary angiography, 298 lesions
Lesion length, mm 11.1 6.9
Minimum lumen diameter, mm 0.9 0.4
Reference diameter, mm 2.6 0.6
Diameter stenosis, % 51.6 13.2
Values are mean SD or n (%).
Figure 2. Relationship Between FFR and Maximal Angiographic Stenosis
Obtained by QCA
FFR  fractional ﬂow reserve; QCA  quantitative coronary angiography;
r  correlation coefﬁcient.iameter stenosis (r0.282, p 0.001) and there was no
ifference in FFR between the vessels with 50% and
50% stenosis (0.73  0.11 vs. 0.76  0.12, p  0.231).
ean distal FFR before PCI was 0.74  0.11 in all vessels.
n total, 116 stents (70 proximal and 46 distal) were
mplanted and revascularization was deferred in 61.1% (182
f 298) of lesions. Two or more stents were implanted in
nly 26 vessels (18.4%). In 89 vessels with an FFR 0.8,
aseline FFR was 0.67  0.09 and increased to 0.84  0.07
fter stenting (p  0.001).
The pressure step-up of the primary target lesion was
9.7  6.6 mm Hg, and all primary target lesions had
tep-up of more than 10 mm Hg. When the primary target
esion was a proximal lesion, FFR was increased from
.69  0.08 to 0.84  0.08 (21.7% increment) after
tenting. In cases of distal lesions, stenting increased FFR
rom 0.66  0.10 to 0.87  0.05 (31.8% increment). After
tenting the primary target lesion, pressure step-up of a
onprimary target lesion was increased from 7.7 5.9 mm Hg
o 10.9  7.8 mm Hg (p  0.013). Figure 3 shows the
ssociation between apparent and true FFR of nonprimary
arget lesions. When the vessels with an initial FFR 0.8
as divided into 2 groups according to the FFR after first
tenting (FFR 0.8 vs. FFR 0.8), there were no differ-
nces in baseline angiographic and physiological parameters
etween the 2 groups (Table 2). There was a trend toward
higher pressure step-up of nonprimary target lesion(s)
Figure 3. Relationship Between Apparent and True FFR of Nonprimary
Target Lesions
Proximal lesion is the primary target lesion and distal lesion is a nonpri-
mary target lesion (open circles); distal lesion is the primary target lesion
and proximal lesion is a nonprimary target lesion (solid circles). Abbrevia-
tions as in Figure 2.
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1017before intervention in patients with an FFR 0.8 after
stenting the primary target lesion (9.7 6.2 mm Hg vs. 6.9
.7 mm Hg, p  0.094).
During the mean follow-up of 501  311 (median 509)
ays, there was only 1 target vessel revascularization that
ccurred due to in-stent restenosis. There were no events
elated to deferred lesions. One noncardiac death (due to
cute subdural hemorrhage) and 1 nontarget vessel-related
yocardial infarction occurred during follow-up (Table 3).
iscussion
The present study demonstrated that FFR measurement
with repetitive pullback pressure recordings is safe and
useful to determine the proper target lesions for revascular-
ization with DES and can reduce unnecessary intervention
in patients with serial stenoses in 1 coronary artery.
FFR is a well-established physiologic parameter for the
assessment of the hemodynamic significance of coronary
stenosis (7,12–14). However, clinical application of FFR in
vessels with multiple stenoses is not easy. In cases of
multiple serial stenoses, 1 stenosis influences the FFR of the
others, which complicates the determination of FFR of each
individual stenosis (9,10). In this situation, pullback pres-
sure recordings under maximal hyperemia have been known
to be a useful and practical method to identify the stenosis
Table 2. Comparison of Angiographic and Physiological Characteristics
Between 2 Groups Divided by FFR After Stenting the Primary
Target Lesion
Characteristic
FFR <0.8
(n  17)
FFR >0.8
(n  72) p Value
Locations
Left anterior descending artery 16 (94.1) 54 (75.0) 0.198
Left circumﬂex artery 1 (5.9) 10 (13.9)
Right coronary artery 0 8 (11.1)
Quantitative coronary angiography
Primary target (ﬁrst stented) lesion
Lesion length, mm 8.8 4.1 10.4 5.3 0.355
Minimum lumen diameter, mm 1.1 0.3 1.4 0.6 0.244
Reference diameter, mm 2.9 0.3 2.6 0.6 0.233
Diameter stenosis, % 59.3 11.8 55.5 14.9 0.434
Nonprimary target lesion
Lesion length, mm 13.4 7.1 10.9 6.6 0.285
Minimum lumen diameter, mm 1.3 0.3 1.5 0.6 0.275
Reference diameter, mm 2.7 0.4 2.6 0.6 0.651
Diameter stenosis, % 51.1 11.0 49.6 12.6 0.743
FFR before stenting 0.68 0.09 0.68 0.08 0.786
Pressure step-up before stenting
Primary target lesion, mm Hg 19.2 6.2 19.9 6.9 0.729
Nonprimary target lesion, mm Hg 9.7 6.2 6.9 4.7 0.094
Values are mean SD or n (%).
FFR fractional flow reserve.that has hemodynamic significance requiring revasculariza-tion (9,10). In our study of 141 vessels with 298 interme-
diate lesions, 239 FFR measurements were required to
perform the FFR-guided revascularization strategy. How-
ever, there were no procedure-related complications, dem-
onstrating that this approach can provide a safe and feasible
physiological assessment for patients with serial stenoses in
a real-world practice.
When multiple stenoses exist in 1 vessel, the functional
significance of each stenosis can be underestimated due to
hemodynamic interaction among the lesions (9,10). There-
fore, the functional significance of a nonprimary target
lesion should be reassessed after the treatment of a primary
target lesion. Like previous reports (9,10), our study showed
that true FFR was lower than apparent FFR in both
proximal and distal stenoses and the pressure step-up of a
nonprimary target lesion was increased from 7.7 5.9 mm Hg
to 10.9  7.8 mm Hg after stenting the primary target
esion. In addition, there was no difference in baseline
ngiographic and physiological characteristics that can pre-
ict the FFR 0.8 after first stenting. All of these findings
mphasize the importance of a repeated measurement of
FR after stenting the primary target lesion to accurately
ssess the functional significance of nonprimary target
esions. Otherwise, functionally significant lesions can be
eft untreated. The increment of pressure gradient across the
onprimary target lesion after PCI of primary target lesion
as less than that from the previous study by Pijls et al. (10).
his difference seems to be due to the differences in lesion
haracteristics and severity of stenosis between the 2 studies.
It is well known that stent placement should be per-
ormed only for functionally significant stenosis (15,16). In
his study, PCI was deferred in 182 lesions of 298 lesions
61.1%) based on the FFR value and only 26 vessels (18.4%)
equired more than 2 stents. During mean follow-up of
01  311 days, there was no clinical event related to
eferred lesions. Considering the excellent clinical outcomes
nd the number of stents saved in our study, FFR measure-
ent with pullback pressure tracing in patients with serial
tenoses can maximize the benefit of PCI with DES, reduce
he number of implanted stents, and minimize stent-related
omplications. This study’s results are in line with the
esults of the FAME (Fractional Flow Reserve Versus
ngiography for Multivessel Evaluation) study (11) and
Table 3. Clinical Outcomes of FFR-Guided Revascularization in Patients
With Serial Stenoses
Cardiac death 0
Target vessel-related MI 0
Nontarget vessel-related MI 1
TLR of stented lesion 1
TLR of deferred lesion 0FFR fractional flow reserve; MImyocardial infarction; TLR target lesion revascularization.
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1018show the clinical and economic benefit of FFR measure-
ment in patients with multiple lesions.
Study limitations. First, the number of patients was rela-
ively small, and there was no control group. Second,
ccurate calculation of FFR of each stenosis could not be
erformed in our study, as we did not measure coronary
edge pressure (9,10). However, as balloon occlusion is
equired for the calculation of FFR of each stenosis, it was
ot clinically applicable, as about 40% of the lesions did not
equire coronary intervention.
onclusions
FFR-guided revascularization strategy using pullback pres-
sure tracing method in serial stenoses was safe and effective.
This strategy can reduce unnecessary intervention and
maximize the benefit of PCI with DES in patients with
multiple stenoses within 1 coronary artery.
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